Identifying low-risk cancer patients with pulmonary embolism for early discharge from the emergency department

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study aims to evaluate the effectiveness of various assessment scales used by physicians to identify cancer patients at low risk of developing serious complications from pulmonary thromboembolism (PTE) within 30 days of diagnosis. By analyzing data from patients who presented to the Emergency Department with PTE, the study seeks to determine which patients can be safely discharged early, thereby reducing unnecessary hospital stays. The research will include both retrospective and prospective enrollment of patients diagnosed with PTE during their cancer treatment. The goal is to improve patient care and resource utilization in emergency medicine.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Age ≥ 18 years
* Diagnosis of pulmonary embolism (symptomatic and/or incidental)
* Active onco-haematological disease (disease followed in oncological/haematological and/or metastatic setting)
* Informed consent to the study

Exclusion Criteria:

* Patients returning to the Emergency Department for complications related to previously diagnosed pulmonary embolism

Where it's running

• Eleonora Tubertini
  Bologna, Italy Recruiting

Study contacts

• Principal investigator: Eleonora Tubertini, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
• Study coordinator: Eleonora Tubertini, MD
• Email: eleonora.tubertini@aosp.bo.it
• Phone: +39 051943435

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Using bedside electrical impedance tomography to detect pulmonary hypertension

  We will test whether a non-invasive bedside scan called electrical impedance tomography (EIT) can detect pulmonary hypertension in adults who are already having a right heart catheterization.

  Recruiting University of Sao Paulo General Hospital · São Paulo, São Paulo · NCT07453017

• Smart technology for patient-centered care in pulmonary embolism

  A smartphone-based program using wearable tech and AI will help people with pulmonary embolism manage their health and see if it improves long-term outcomes.

  Recruiting Navy General Hospital, Beijing · Beijing, Beijing Municipality · NCT06382038

• Registry of catheter interventions for pulmonary embolism

  This study looks at how safe and effective different catheter treatments are for people with moderate to high-risk pulmonary embolism.

  Recruiting Hospital San Carlos, Madrid · Madrid, Madrid · NCT06348459

• Personalized anticoagulant therapy for pulmonary thromboembolism

  This study is trying to see how different factors affect the safety and effectiveness of blood-thinning treatments for older adults and people with kidney issues or cancer who have pulmonary thromboembolism.

  Recruiting Xiangya Hospital of Central South University · Changsha, Hunan · NCT06341231

• How lung capillary surface area changes after balloon pulmonary angioplasty for CTEPH

  This will test whether balloon pulmonary angioplasty restores downstream functional pulmonary capillary surface area in people with chronic thromboembolic pulmonary hypertension.

  Recruiting Jewish General Hospital · Montreal, Quebec · NCT05719415

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.